Literature DB >> 7243443

Recrudescence and relapse in bacterial meningitis of childhood.

U B Schaad, J D Nelson, G H McCracken.   

Abstract

Antibiotic therapy of bacterial meningitis in children may be complicated by reappearance of bacteria in cerebrospinal fluid during therapy (recrudescence) or within three weeks after therapy is stopped (relapse). Clinical and laboratory features of six children with recrudescence and of 21 children with relapse were reviewed. These complications occurred mainly in infants less than 2 years of age and comprised less than 1% of all cases of bacterial meningitis. Neither the initial nor the follow-up CSF findings were predictive of recrudescence or relapse. Prolonged or secondary fever was unrelated to these complications. Recrudescence was usually caused by inappropriate therapy whereas relapse after adequate therapy of bacterial meningitis was usually ascribed to persistence of infection in meningeal or parameningeal foci. Relapse did not become manifest until three or more days after discontinuation of therapy. It is concluded that routine examination of CSF at the end of adequate anti-microbial therapy is not necessary or useful when the patient has exhibited a satisfactory clinical response. Furthermore, the commonly recommended observation period of 48 hours in the hospital after discontinuation of therapy is not justified for a patient who has had an uneventful course.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7243443

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Chemoprophylaxis for Haemophilus influenzae type b.

Authors:  K A Cartwright; N T Begg; D Hull
Journal:  BMJ       Date:  1991-03-09

2.  Bacterial meningitis in India: an IJP survey.

Authors:  S K Kabra; P Kumar; I C Verma; D Mukherjee; B H Chowdhary; S Sengupta; R N Singh; S P Khatua; N Miglani; K M Sehai
Journal:  Indian J Pediatr       Date:  1991 Jul-Aug       Impact factor: 1.967

3.  Novel approaches to therapy of meningitis.

Authors:  G H McCracken
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

Review 4.  Cephalosporins in adult meningitis.

Authors:  T R Beam
Journal:  Bull N Y Acad Med       Date:  1984-05

5.  Meningitis in infancy.

Authors:  M Suri; B N Walia
Journal:  Indian J Pediatr       Date:  1983 Jul-Aug       Impact factor: 1.967

Review 6.  Neonatal meningitis.

Authors:  P T Heath; N K Nik Yusoff; C J Baker
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-05       Impact factor: 5.747

7.  Cefotaxime in pneumococcal meningitis.

Authors:  H Lecour; A Seara; A M Miranda; J Cordeiro
Journal:  Infection       Date:  1985       Impact factor: 3.553

Review 8.  Treatment of bacterial meningitis.

Authors:  U B Schaad
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

9.  Cefuroxime in bacterial meningitis.

Authors:  J Pfenninger; U B Schaad; J Lütschg; A Nussbaumer; U Zellweger
Journal:  Arch Dis Child       Date:  1982-07       Impact factor: 3.791

10.  Recurrent Streptococcus Pneumoniae 23 F meningitis due to cerebrospinal fluid leakage from the ear cannel: a case report.

Authors:  Yu-Cheng Li; Chun-Yu Chen; Kang-Hsi Wu; Huang-Tsung Kuo; Han-Ping Wu
Journal:  BMC Pediatr       Date:  2015-11-25       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.